Skip to main content
Top
Published in: Dermatology and Therapy 10/2023

Open Access 24-08-2023 | Atopic Dermatitis | Brief Report

History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis

Authors: Mary C. Moran, Alanna Klose, Takeshi Yoshida, Anna De Benedetto, Lynda C. Schneider, Peck Y. Ong, Eric L. Simpson, Donald Y. M. Leung, Benjamin L. Miller, Christopher L. Seplaki, Lisa A. Beck

Published in: Dermatology and Therapy | Issue 10/2023

Login to get access

Abstract

Introduction

Patients with atopic dermatitis (AD) are uniquely susceptible to a number of serious viral skin complications, including eczema herpeticum (EH), caused by herpes simplex virus. This study explored the associations between biomarkers of epithelial barrier dysfunction, type 2 immunity, Staphylococcus aureus infection, and S. aureus-specific immunoglobulin responses in a cohort of AD subjects with and without a history of EH (EH+ and EH−, respectively).

Methods

A total of 112 subjects with AD (56 EH+, 56 EH−), matched by age and AD severity, were selected from a registry of over 3000 AD subjects. Logistic regression was used to test the association between history of S. aureus skin infection and history of EH, while controlling for a number of confounders.

Results

Compared to those without a history of S. aureus skin infection, subjects with a history of S. aureus skin infection were found to have more than sixfold increased odds of having a history of EH (6.60, 95% confidence interval [CI]: 2.00–21.83), after adjusting for history of other viral skin infections (molluscum contagiosum virus, human papillomavirus), serum total IgE, and IgG against the S. aureus virulence factor SElX.

Conclusions

These findings indicate an important relationship between S. aureus skin infections and EH.
Literature
1.
go back to reference Xia J, Huang CL, Chu P, Kroshinsky D. Eczema monkeypoxicum: report of monkeypox transmission in a patient with atopic dermatitis. JAAD Case Rep. 2022;29:95–9.CrossRefPubMedPubMedCentral Xia J, Huang CL, Chu P, Kroshinsky D. Eczema monkeypoxicum: report of monkeypox transmission in a patient with atopic dermatitis. JAAD Case Rep. 2022;29:95–9.CrossRefPubMedPubMedCentral
2.
go back to reference Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329–37.CrossRefPubMed Ong PY, Leung DY. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329–37.CrossRefPubMed
3.
go back to reference Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009;124(2):260–9.e7.CrossRefPubMedPubMedCentral Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. 2009;124(2):260–9.e7.CrossRefPubMedPubMedCentral
4.
go back to reference Schlievert PM, Roller RJ, Kilgore SH, et al. Staphylococcal TSST-1 association with eczema herpeticum in humans. mSphere. 2021;6(4):e0060821.CrossRefPubMed Schlievert PM, Roller RJ, Kilgore SH, et al. Staphylococcal TSST-1 association with eczema herpeticum in humans. mSphere. 2021;6(4):e0060821.CrossRefPubMed
5.
go back to reference Klose AM, Daiss JL, Ho L, et al. StaphAIR: a label-free antigen microarray approach to detecting anti-staphylococcus aureus antibody responses in orthopedic infections. Anal Chem. 2021;93(40):13580–8.CrossRefPubMed Klose AM, Daiss JL, Ho L, et al. StaphAIR: a label-free antigen microarray approach to detecting anti-staphylococcus aureus antibody responses in orthopedic infections. Anal Chem. 2021;93(40):13580–8.CrossRefPubMed
6.
7.
go back to reference Totte JEE, Pardo LM, Fieten KB, et al. IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children. Br J Dermatol. 2018;179(1):118–26.CrossRefPubMed Totte JEE, Pardo LM, Fieten KB, et al. IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children. Br J Dermatol. 2018;179(1):118–26.CrossRefPubMed
8.
go back to reference Simpson EL, Villarreal M, Jepson B, et al. Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype. J Invest Dermatol. 2018;138(10):2224–33.CrossRefPubMedPubMedCentral Simpson EL, Villarreal M, Jepson B, et al. Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype. J Invest Dermatol. 2018;138(10):2224–33.CrossRefPubMedPubMedCentral
9.
go back to reference Addor FA, Takaoka R, Rivitti EA, Aoki V. Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity. Int J Dermatol. 2012;51(6):672–6.CrossRefPubMed Addor FA, Takaoka R, Rivitti EA, Aoki V. Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity. Int J Dermatol. 2012;51(6):672–6.CrossRefPubMed
10.
go back to reference Agner T. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. Acta Derm Venereol. 1991;71(4):296–300.CrossRefPubMed Agner T. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. Acta Derm Venereol. 1991;71(4):296–300.CrossRefPubMed
11.
go back to reference Finlay AY, Nicholls S, King CS, Marks R. The “dry” non-eczematous skin associated with atopic eczema. Br J Dermatol. 1980;103(3):249–56.CrossRefPubMed Finlay AY, Nicholls S, King CS, Marks R. The “dry” non-eczematous skin associated with atopic eczema. Br J Dermatol. 1980;103(3):249–56.CrossRefPubMed
12.
go back to reference Rinaldi AO, Korsfeldt A, Ward S, et al. Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis. Allergy. 2021;76(10):3066–79.CrossRefPubMed Rinaldi AO, Korsfeldt A, Ward S, et al. Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis. Allergy. 2021;76(10):3066–79.CrossRefPubMed
13.
go back to reference Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75(6):429–33.CrossRefPubMed Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75(6):429–33.CrossRefPubMed
14.
go back to reference Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol. 2003;49(2):198–205.CrossRefPubMed Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol. 2003;49(2):198–205.CrossRefPubMed
15.
go back to reference Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 1992;185(2):88–92.CrossRefPubMed Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 1992;185(2):88–92.CrossRefPubMed
16.
go back to reference Wuthrich B. Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases. Clin Allergy. 1978;8(3):241–8.CrossRefPubMed Wuthrich B. Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases. Clin Allergy. 1978;8(3):241–8.CrossRefPubMed
17.
go back to reference Tuffs SW, James DBA, Bestebroer J, et al. The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function. PLoS Pathog. 2017;13(9): e1006461.CrossRefPubMedPubMedCentral Tuffs SW, James DBA, Bestebroer J, et al. The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function. PLoS Pathog. 2017;13(9): e1006461.CrossRefPubMedPubMedCentral
19.
go back to reference Wilson GJ, Seo KS, Cartwright RA, et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 2011;7(10): e1002271.CrossRefPubMedPubMedCentral Wilson GJ, Seo KS, Cartwright RA, et al. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog. 2011;7(10): e1002271.CrossRefPubMedPubMedCentral
21.
go back to reference Guerra FE, Borgogna TR, Patel DM, Sward EW, Voyich JM. Epic immune battles of history: neutrophils vs Staphylococcus aureus. Front Cell Infect Microbiol. 2017;7:286.CrossRefPubMedPubMedCentral Guerra FE, Borgogna TR, Patel DM, Sward EW, Voyich JM. Epic immune battles of history: neutrophils vs Staphylococcus aureus. Front Cell Infect Microbiol. 2017;7:286.CrossRefPubMedPubMedCentral
22.
go back to reference Miller LS, Fowler VG, Shukla SK, Rose WE, Proctor RA. Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol Rev. 2020;44(1):123–53.CrossRefPubMed Miller LS, Fowler VG, Shukla SK, Rose WE, Proctor RA. Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol Rev. 2020;44(1):123–53.CrossRefPubMed
Metadata
Title
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis
Authors
Mary C. Moran
Alanna Klose
Takeshi Yoshida
Anna De Benedetto
Lynda C. Schneider
Peck Y. Ong
Eric L. Simpson
Donald Y. M. Leung
Benjamin L. Miller
Christopher L. Seplaki
Lisa A. Beck
Publication date
24-08-2023
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 10/2023
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-023-00996-y

Other articles of this Issue 10/2023

Dermatology and Therapy 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.